PMV Pharmaceuticals Announces Participation at the Bank of America Securities 2021 Napa Biopharma Virtual Conference

(Moderate)

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Rhea-AI Summary

PMV Pharmaceuticals (Nasdaq: PMVP) announced its participation in the Bank of America Securities 2021 Napa Biopharma Virtual Conference, where David H. Mack, Ph.D., President & CEO, will present on June 14, 2021, at 2:30 PM ET. The company specializes in developing tumor-agnostic therapies targeting p53 mutations, prevalent in nearly half of all cancers. PMV Pharma combines over 40 years of p53 biology expertise with a strong pharmaceutical development focus. For more information, visit pmvpharma.com.

Positive

Participation in notable Bank of America Securities conference enhances visibility.
Focus on p53 mutations aligns with significant cancer treatment opportunities.

Negative

None.

Argus Session date unavailable

-0.57% session move Open Argus

Details

News Market Reaction – PMVP

The recorded move for PMVP in the trading session of this news was -0.57%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

06/09/2021 - 08:00 AM EDT

CRANBURY, N.J., June 09, 2021 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (Nasdaq: PMVP), a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting p53 mutants, today announced that David H. Mack, Ph.D., President & Chief Executive Officer, will present at the Bank of America Securities 2021 Napa Biopharma Virtual Conference on Monday, June 14th.

Details on the presentation can be found below.

Bank of America Securities 2021 Napa Biopharma Virtual Conference
Date:	Monday, June 14, 2021
Time:	2:30 PM ET

About PMV Pharma

PMV Pharma is a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting p53 mutants. p53 mutations are found in approximately half of all cancers. The field of p53 biology was established by our co-founder Dr. Arnold Levine when he discovered the p53 protein in 1979. Bringing together leaders in the field to utilize over four decades of p53 biology, PMV Pharma combines unique biological understanding with pharmaceutical development focus. PMV Pharma is headquartered in Cranbury, New Jersey. For more information, please visit www.pmvpharma.com.

Contact

For Investors & Media:

Winston Kung
Chief Financial Officer
investors@pmvpharma.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What conference is PMV Pharmaceuticals participating in?

PMV Pharmaceuticals will present at the Bank of America Securities 2021 Napa Biopharma Virtual Conference.

When will David H. Mack present at the conference?

David H. Mack will present on June 14, 2021, at 2:30 PM ET.

What is the focus of PMV Pharmaceuticals' therapies?

PMV Pharmaceuticals focuses on therapies targeting p53 mutations, which are found in approximately 50% of all cancers.

What is the significance of p53 mutations in cancer treatment?

P53 mutations are significant because they are prevalent in nearly half of all cancers, making targeted therapies crucial.

PMV Pharmaceuticals Announces Participation at the Bank of America Securities 2021 Napa Biopharma Virtual Conference